SonoWorld.com uses cookies to improve your experience on the site. Your continued use of the site constitutes your acceptance of use of cookies on this site.
Find out more about how SonoWorld uses cookies. I’m OK with Cookies from SonoWorld - stop showing me this banner.
×
 
169,794 Registered Members as of 12/10/2018.
Other » Contrast Agents
Hemangioma of the liver
« Back to Listing
 
 
Presentation The patient is a 53 y.o male smoker with findings of suspicious opacity on a chest plain film.
 
 
 
Caption: CT scan
Description: Unenhanced CT scan found a 20 mm nodule in the segment IV of the liver
 
 
 
Caption: Transverse scan of liver
Description: Ultrasound of the lesion demonstrated on CT shows a predominately hyperechoic mass with mixed echogenicity, edge shadows and no significant posterior enhancement.
 
 
 
Caption: Baseline prior to injection of ultrasound contrast agent
Description: The lesion appears slightly hyperechoic at baseline US
 
 
 
Caption: Post injection 1
Description: After contrast agent injection there is peripheral globular enhancement and centripetal filling-in of the lesion,
 
 
 
Caption: Post injection 2
Description: There is a continuation of peripheral globular enhancement and centripetal filling-in of the lesion with no wash-out.
 
 
Caption: Video clip
Description: After Sonovue injection, we observe peripheral globular enhancement and centripetal filling-in of the lesion with no wash-out. This enhancement pattern is characteristic of Hemangioma.
 
Differential Diagnosis After CT and US: Metastasis, hemangioma, HCC, cholangiocarcinoma, adenoma
 
Final Diagnosis Hemangioma of the liver
 
Discussion The lesion appears slightly hyperechoic at baseline ultrasound.
After contrast agent injection, we observe peripheral globular enhancement and centripetal filling-in of the lesion with no wash-out.
This enhancement pattern is characteristic of Hemangioma.
 
Technical Details Contrast agent:  Sonovue, Bracco Inc.   
 
Other contents by this AuthorOther Cases in This Category